Immunogenetics of toxoplasma gondii informs vaccine design

Tools

Henriquez, Fiona L. and Woods, Stuart and Cong, Hua and McLeod, Rima and Roberts, Craig (2010) Immunogenetics of toxoplasma gondii informs vaccine design. Trends in Parasitology, 26 (11). pp. 550-555. ISSN 1471-4922 (https://doi.org/10.1016/j.pt.2010.06.004)

Full text not available in this repository.Request a copy

Abstract

A series of studies over 20 years mapped resistance to toxoplasmic encephalitis in mice to major histocompatibility complex class I (MHC I) and ultimately, more precisely the Ld region This is consistent with contemporary functional studies that demonstrated a protective role for CD8(+) T cells Recent studies have demonstrated that the Ld gene product presents a number of immunodominant Toxoplasma gondii-derived peptides in the murine models, providing a paradigm for vaccine design The almost complete sequencing of the genomes of the predominant strains of T gondii in conjunction with the development of predictive binding algorithms for MHC I peptides in humans now offers a new opportunity for vaccine development against this medically important pathogen

ORCID iDs

Henriquez, Fiona L., Woods, Stuart ORCID logoORCID: https://orcid.org/0000-0002-3798-2074, Cong, Hua, McLeod, Rima and Roberts, Craig ORCID logoORCID: https://orcid.org/0000-0002-0653-835X;
CORE (COnnecting REpositories)